Statistically significant differences were observed in sex; age; CA19-9 and CEA levels; size, location, shape, and lobulation; lymphadenopathy; pancreatic atrophy; and duct characteristics, findings consistent with previous studies [23, 32, 33]. The gene discussed is CEACAM5; the disease is Lymphadenopathy.